Founder and President, Rare Genomics Institute; Director of Clinical Genomics, National Cancer Institute, National Institutes of Health
Jimmy Lin is founder and president of Rare Genomics Institute, a nonprofit that provides patients and families a crowdfunding platform and access to physicians, scientists, and cutting-edge research to custom design personalized research projects for rare diseases. He is director of clinical genomics at the genetics branch of the National Institutes of Health/National Cancer Institute. Previously, he led computational analysis of the first-ever exome sequencing studies for any human disease at Johns Hopkins. He has been published in Science, Nature, Cell, Nature Genetics, and Nature Biotechnology and featured in Forbes, Bloomberg, The Washington Post, Huffington Post and other publications. He was a 2012 TED Fellow.